Antivenom for sale? Availability and affordability of snakebite medicines across public and private health facilities in Rwanda
Open Access
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Snake bite: a global failure to act costs thousands of lives each yearBMJ, 2015
- Assessment of Essential Medicines Stock-Outs at Health Centers in Burera District in Northern RwandaRwanda Journal, 2015
- Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?PLOS Neglected Tropical Diseases, 2015
- Consequences of Neglect: Analysis of the Sub-Saharan African Snake Antivenom Market and the Global ContextPLOS Neglected Tropical Diseases, 2012
- Ending the drought: New strategies for improving the flow of affordable, effective antivenoms in Asia and AfricaJournal of Proteomics, 2011
- Estimate of the burden of snakebites in sub-Saharan Africa: A meta-analytic approachToxicon, 2011
- Snake Envenoming: A Disease of PovertyPLOS Neglected Tropical Diseases, 2009
- Unscrupulous marketing of snake bite antivenoms in Africa and Papua New Guinea: choosing the right product—‘What's in a name?’Transactions of the Royal Society of Tropical Medicine and Hygiene, 2008
- Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillanceTransactions of the Royal Society of Tropical Medicine and Hygiene, 2008
- Study of the efficacy of the black stone on envenomation by snake bite in the murine modelToxicon, 2007